Evidence map›Paper›PMID 39398062›Full record

ArticleHeliyon2024

Identification of crucial genes and possible molecular pathways associated with active vitamin D intervention in diabetic kidney disease.

MingXia Zhang, Mi Tao, Quan Cao, Yousheng Cai, Lin Ding, Zhenni Li, Wen Chen, Ping Gao, Lunzhi Liu

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

MingXia ZhangDepartment of Nephrology, Minda Hospital Affiliated to Hubei Minzu University, Hubei Clinical Research Center for Kidney Disease, Enshi, China.
Mi TaoDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Quan CaoDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Yousheng CaiDepartment of Nephrology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
Lin DingDepartment of Nephrology, Minda Hospital Affiliated to Hubei Minzu University, Hubei Clinical Research Center for Kidney Disease, Enshi, China.
Zhenni LiDepartment of Nephrology, Minda Hospital Affiliated to Hubei Minzu University, Hubei Clinical Research Center for Kidney Disease, Enshi, China.
Wen ChenDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Ping GaoDepartment of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China.
Lunzhi LiuDepartment of Nephrology, Minda Hospital Affiliated to Hubei Minzu University, Hubei Clinical Research Center for Kidney Disease, Enshi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A significant cause of advanced renal failure is diabetic nephropathy (DKD), with few treatment options available. Calcitriol shows potential in addressing fibrosis related to DKD, though its molecular mechanisms remain poorly understood. This research seeks to pinpoint the crucial genes and pathways influenced by calcitriol within the scope of DKD-related fibrosis. Methods: Single-cell gene expression profiling of calcitriol treated DKD rat kidney tissue and screening of fibrosis-associated cell subsets. Mendelian randomization and enrichment analyses (CIBERSORT, GSVA, GSEA, Motif Enrichment) were used to explore gene-immune cell interactions and signaling pathways. Key findings were validated using independent datasets and protein expression data from the Human Protein Atlas. Results: Calcitriol treatment reduced proliferative cell populations and highlighted the FoxO signaling pathway's role in DKD. Conclusion: Our results suggest that calcitriol modulates DKD fibrosis through the FoxO pathway, with

Indexed as

BiomarkersCalcitriolDiabetic kidney diseaseFibrosisFoxO pathway

Identifiers

PMID39398062
PMCPMC11470520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.